Inspiration Healthcare continues fight against COVID-19
(AIM: IHC) has announced it has received further orders for medical supplies and ventilation equipment from the UK National Health Service (NHS) to assist in the fight against Covid-19 (Coronavirus).
This follow-on order from the NHS follows the largest order the Company has received for ventilators for £1.25m announced earlier in the week, are worth over £4m in aggregate. The Company is working with various global suppliers expediate delivery as soon possible.
Consensus revenue forecast for Inspiration is currently £20.4m for FY21e before the announcements of these NHS orders. Clearly the risk is now on the upside for consensus estimates. Inspiration is currently valued on a FY1 1.3x and 9.7x EV/Sales and EV/Ebitda multiples respectively.
Neil Campbell, Inspiration Healthcare's CEO commented, "I'm delighted that Inspiration Healthcare has been able to benefit from our commercial relationships with critical care equipment manufacturers and source such large quantities of this very specialist equipment, working closely with the DHSC to find solutions during this difficult time. Inspiration Healthcare's senior directors as well as our teams working all over the UK have played a key role in securing these supplies, which in total are considerably larger than we have ever received in the past. In this fast-changing situation we remain subject to a large number of factors which are outside of our control but confident that we will continue to provide solutions going forwards."
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.